Stephen P Baker

Stephen P Baker, Ph.D.

EMERITUS PROF

Department: MD-PHARMACOLOGY / THERAPEUTICS
Business Phone: (352) 294-5358
Business Email: spbaker@ufl.edu

Teaching Profile

Courses Taught
2011-2014
DEN6262 Prin of Pharmacology
2014
MDU4002 Introduction to Medical Science Seminar 2
2013
BMS6031 Foundations of Med
2006-2008,2011
GMS7593 Topics in Pharmacology and Toxicology
2006,2008-2010,2010
GMS6590 Seminar in Pharmacology
2006-2009
GMS6009 Drug Action Principle

Research Profile

Baker’s research is in the area of cell surface receptors and their coupled signal transduction processes, which involves how cells respond to chemical mediators in their external environment. The model systems under study mainly focus on the beta-adrenergic and adenosine receptors and their subtypes, which mediate a number of important cellular and physiological responses and are targets for drug development. His specific interests include the mechanisms of receptor activation and mechanisms of interaction between receptors (cross-talk), which affect intracellular mediators differently. The design and synthesis of novel receptor ligands are also of interest and include structure-activity relationships for partial agonists, enhanced receptor subtype selectivity, and bifunctional ligands, where a single chemical entity can affect the activity of more than one receptor. Irreversible receptor ligands are also used to study the relationship between receptor occupancy and response (coupling efficiency) and the mechanisms for how this relationship changes during health and disease.

Publications

Academic Articles
2018
Human-relevant potency threshold (HRPT) for ERα agonism.
Archives of toxicology. 92(5):1685-1702 [DOI] 10.1007/s00204-018-2186-z. [PMID] 29632997.
2013
Effect of linker length and composition on heterobivalent ligand-mediated receptor cross-talk between the A1 adenosine and β2 adrenergic receptors.
ChemMedChem. 8(12):2036-46 [DOI] 10.1002/cmdc.201300286. [PMID] 24106065.
2013
Potency matters: thresholds govern endocrine activity.
Regulatory toxicology and pharmacology : RTP. 67(1):83-8 [DOI] 10.1016/j.yrtph.2013.06.007. [PMID] 23838262.
2012
Disruption of IFT complex A causes cystic kidneys without mitotic spindle misorientation.
Journal of the American Society of Nephrology : JASN. 23(4):641-51 [DOI] 10.1681/ASN.2011080829. [PMID] 22282595.
2012
Synthesis and biological evaluation of adenosines with heterobicyclic and polycyclic N(6)-substituents as adenosine A(1) receptor agonists.
ChemMedChem. 7(7):1191-201 [DOI] 10.1002/cmdc.201200208. [PMID] 22684887.
2011
Antiadrenergic and hemodynamic effects of ranolazine in conscious dogs.
Journal of cardiovascular pharmacology. 57(6):639-47 [DOI] 10.1097/FJC.0b013e31821458e8. [PMID] 21633249.
2008
N6-substituted C5′-modified adenosines as A1 adenosine receptor agonists.
Bioorganic & medicinal chemistry. 16(4):1861-73 [PMID] 18042389.
2008
Synthesis of bivalent beta2-adrenergic and adenosine A1 receptor ligands.
Journal of medicinal chemistry. 51(19):6128-37 [DOI] 10.1021/jm800613s. [PMID] 18783211.
2007
Structure-activity relationships of adenosines with heterocyclic N6-substituents.
Bioorganic & medicinal chemistry letters. 17(24):6779-84 [PMID] 17967536.
2006
Dihydropyridine receptors and type 1 ryanodine receptors constitute the molecular machinery for voltage-induced Ca2+ release in nerve terminals.
The Journal of neuroscience : the official journal of the Society for Neuroscience. 26(29):7565-74 [PMID] 16855084.
2006
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor.
Bioorganic & medicinal chemistry letters. 16(21):5530-3 [PMID] 16931014.
2005
Histone methylation at gene promoters is associated with developmental regulation and region-specific expression of ionotropic and metabotropic glutamate receptors in human brain.
Journal of neurochemistry. 94(2):324-36 [PMID] 15998284.
2005
Long-term changes in glutamatergic synaptic transmission in phenylketonuria.
Brain : a journal of neurology. 128(Pt 2):300-7 [PMID] 15634735.
2004
New potent and selective A1 adenosine receptor agonists.
Bioorganic & medicinal chemistry. 12(18):4877-84 [PMID] 15336267.
2002
New 2,N6-disubstituted adenosines: potent and selective A1 adenosine receptor agonists.
Bioorganic & medicinal chemistry. 10(4):1115-22 [PMID] 11836122.
2002
New irreversible adenosine A(1) antagonists based on FSCPX.
Bioorganic & medicinal chemistry letters. 12(21):3179-82 [PMID] 12372528.
2001
Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists.
The Journal of pharmacology and experimental therapeutics. 298(1):209-18 [PMID] 11408544.
2000
Differential A(1)-adenosine receptor reserve for inhibition of cyclic AMP accumulation and G-protein activation in DDT(1) MF-2 cells.
British journal of pharmacology. 130(5):1156-64 [PMID] 10882402.
2000
Fluorosulfonyl-substituted xanthines as selective irreversible antagonists for the A(1)-adenosine receptor.
Journal of medicinal chemistry. 43(26):4973-80 [PMID] 11150167.
1999
Adenosine receptor ligands with oxygenated N6-substituents.
Bioorganic & medicinal chemistry letters. 9(7):933-6 [PMID] 10230614.
1999
Structure-affinity profile of 8-hydroxycarbostyril-based agonists that dissociate slowly from the beta2-adrenoceptor.
Naunyn-Schmiedeberg's archives of pharmacology. 359(3):168-77 [PMID] 10208303.
1998
A2A-adenosine receptor reserve for coronary vasodilation.
Circulation. 98(7):711-8 [PMID] 9715864.
1998
Irreversible binding of a carbostyril-based agonist and antagonist to the beta-adrenoceptor in DDT1 MF-2 cells and rat aorta.
British journal of pharmacology. 124(1):165-75 [PMID] 9630356.
1998
N6-(5,6-epoxynorbornyl)adenosine analogs as A1 adenosine agonists.
Bioorganic & medicinal chemistry letters. 8(24):3647-8 [PMID] 9934487.
1998
XH-14 analogues as adenosine antagonists.
Bioorganic & medicinal chemistry. 6(9):1517-24 [PMID] 9801823.
1997
Differential A1 adenosine receptor reserve for two actions of adenosine on guinea pig atrial myocytes.
Molecular pharmacology. 52(4):683-91 [PMID] 9380032.
1997
Persistent activation by and receptor reserve for an irreversible A1-adenosine receptor agonist in DDT1 MF-2 cells and in guinea pig heart.
Molecular pharmacology. 52(3):491-8 [PMID] 9281612.
1997
Synthesis and biological evaluation of the enantiomers of the potent and selective A1-adenosine antagonist 1,3-dipropyl-8-[2-(5,6-epoxynorbonyl)]-xanthine.
Journal of medicinal chemistry. 40(12):1773-8 [PMID] 9191953.
1996
A novel irreversible antagonist of the A1-adenosine receptor.
Molecular pharmacology. 50(1):196-205 [PMID] 8700113.
1996
Binding of the novel nonxanthine A2A adenosine receptor antagonist [3H]SCH58261 to coronary artery membranes.
Circulation research. 79(6):1153-60 [PMID] 8943953.
1995
1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells.
The Journal of pharmacology and experimental therapeutics. 275(3):1167-76 [PMID] 8531078.
1994
Substituted 1,3-dipropylxanthines as irreversible antagonists of A1 adenosine receptors.
Journal of medicinal chemistry. 37(17):2704-12 [PMID] 8064798.
1993
Selective A2-adenosine receptor agonists do not alter action potential duration, twitch shortening, or cAMP accumulation in guinea pig, rat, or rabbit isolated ventricular myocytes.
Circulation research. 72(1):194-205 [PMID] 8380261.
1993
The cellular and physiological actions of insulin in the central nervous system.
Neurochemistry international. 22(1):1-10 [PMID] 8443563.
1991
Effects of chronic hypoxia during maturation on the negative chronotropic effect of [H+] on the rabbit sino-atrial node.
Biology of the neonate. 59(2):109-13 [PMID] 2036467.
1990
Effect of acetylethylcholine mustard on muscarinic receptor-coupled attenuation of cAMP formation in intact GH3 cells.
The Journal of pharmacology and experimental therapeutics. 254(1):136-41 [PMID] 2164088.
1989
Carbostyril-based beta-adrenergic agonists: evidence for long lasting or apparent irreversible receptor binding and activation of adenylate cyclase activity in vitro.
Naunyn-Schmiedeberg's archives of pharmacology. 339(1-2):129-37 [PMID] 2566922.
1989
Cholinergic properties of rat atrial subcellular preparations.
Journal of molecular and cellular cardiology. 21(3):305-13 [PMID] 2746656.
1989
Effect of chronic hypoxia on cardiac beta-adrenergic and muscarinic receptors during maturation.
Research communications in chemical pathology and pharmacology. 63(3):307-15 [PMID] 2543043.
1988
Increased expression of alpha 1-adrenergic receptors in the hypothalamus of spontaneously hypertensive rats.
Brain research. 439(1-2):187-94 [PMID] 2833983.
1988
Irreversible binding and recovery of the norepinephrine uptake system using an alkylating derivative of norepinephrine.
Journal of neurochemistry. 50(4):1044-52 [PMID] 2894406.
1988
Thyroxine, renal beta-adrenergic receptors, and dipsogenesis in food-deprived rats.
The American journal of physiology. 254(1 Pt 2):R33-9 [PMID] 2827530.
1987
Beta-adrenergic responsiveness and cardiac autonomic receptors after implantation of the MtTW15 pituitary adenoma in the rat.
Biochemical pharmacology. 36(8):1297-302 [PMID] 3036164.
1987
Carbostyril derivatives having potent beta-adrenergic agonist properties.
Journal of medicinal chemistry. 30(9):1563-6 [PMID] 2887658.
1987
Chronotropic and inotropic effects on atria of chronic ethanol ingestion in the aging rat.
Alcohol and drug research. 7(4):273-7 [PMID] 3828003.
1987
Depressed atrial inotropic response in the rat with chronic ethanol ingestion.
Alcohol (Fayetteville, N.Y.). 4(1):7-10 [PMID] 3030359.
1987
Effect of long-term ethanol consumption on the rat ventricle.
Alcohol and drug research. 7(5-6):371-81 [PMID] 3040024.
1987
Effects of acetylethylcholine mustard on [3H]quinuclidinyl benzilate binding and acetylcholine release in rat brain synaptosomes.
Journal of neurochemistry. 48(2):477-82 [PMID] 3794717.
1987
Phorbol esters inhibit agonist-stimulated phosphoinositide hydrolysis in neuronal primary cultures.
Brain research. 465(1-2):59-66 [PMID] 2894235.
1986
Characteristics of the beta-adrenoreceptor from neuronal and glial cells in primary cultures of rat brain.
Journal of neurochemistry. 47(4):1318-26 [PMID] 2875131.
1986
Decreased alpha 1-adrenergic receptor-mediated inositide hydrolysis in neurons from hypertensive rat brain.
The American journal of physiology. 251(2 Pt 1):C230-7 [PMID] 2874741.
1986
Differential recovery of beta adrenoreceptor antagonist and agonist high affinity binding sites in the guinea-pig lung after irreversible blockade.
The Journal of pharmacology and experimental therapeutics. 237(3):830-6 [PMID] 2872326.
1986
Effects of choline augmentation on acetylcholine synthesis and release in rat atrial minces.
Life sciences. 39(15):1307-15 [PMID] 3762310.
1986
Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
Molecular pharmacology. 30(5):411-8 [PMID] 3773882.
1986
Possible mechanism for increased beta-adrenergic dipsogenic response in food-deprived rats.
The American journal of physiology. 251(6 Pt 2):R1170-6 [PMID] 3024511.
1986
Potentiation of the negative chronotropic action of verapamil by ethanol.
Journal of cardiovascular pharmacology. 8(4):697-9 [PMID] 2427806.
1986
The effect of chronic ethanol ingestion on the inotropic effect of nifedipine.
Research communications in chemical pathology and pharmacology. 52(2):269-72 [PMID] 3715204.
1985
Age-related changes in cardiac muscarinic receptors: decreased ability of the receptor to form a high affinity agonist binding state.
Journal of gerontology. 40(2):141-6 [PMID] 3973354.
1985
Age-related reductions in rat atrial high affinity choline uptake, ACh synthesis, and ACh release. A brief note.
Mechanisms of ageing and development. 30(2):221-5 [PMID] 2991674.
1985
Irreversible inactivation of the beta-adrenoreceptor by a partial agonist. Evidence for selective loss of the agonist high affinity binding sites.
The Journal of biological chemistry. 260(29):15820-8 [PMID] 2999138.
1985
Negative chronotropic effect of chronic ethanol ingestion in the rat.
Alcohol (Fayetteville, N.Y.). 2(2):309-11 [PMID] 4040379.
1984
Effects of elevated prolactin and its normalization on thyroid hormone, cardiac beta-adrenoreceptor number and beta-adrenergic responsiveness.
Life sciences. 34(9):889-98 [PMID] 6321874.
1984
The effect of bromoacetylalprenololmentane on rat atrial tension development and beta-adrenoreceptors.
European journal of pharmacology. 100(3-4):373-6 [PMID] 6329781.
1984
The resistance of the cardiac muscarinic receptor to chronic ethanol ingestion in the rat.
Substance and alcohol actions/misuse. 5(4):185-92 [PMID] 6543035.
1983
Dependence of beta-adrenergic responsiveness on thyroid state of male rats.
Clinical and experimental pharmacology & physiology. 10(2):101-14 [PMID] 6307562.
1983
The effect of the beta-adrenoreceptor antagonist Ro03-7894 on rat atrial tension development and (-)-[3H]dihydroalprenolol binding to cardiac and lung membranes.
Life sciences. 33(5):459-66 [PMID] 6135967.
1982
Chronic propranolol treatment decreases cardiac beta-adrenoceptors in spontaneously hypertensive rats.
European journal of pharmacology. 78(4):479-82 [PMID] 6281038.
1982
Irreversible blockade of beta adrenoreceptors and their recovery in the rat heart and lung in vivo.
The Journal of pharmacology and experimental therapeutics. 220(2):247-51 [PMID] 6120224.
1982
Regeneration of beta-adrenergic receptors in senescent rats: a study using an irreversible binding antagonist.
Proceedings of the National Academy of Sciences of the United States of America. 79(14):4424-7 [PMID] 6126874.
1981
A minor component of the binding of [3H]guanyl-5′-yl imidodiphosphate to cardiac membranes associated with the activation of adenylate cyclase.
The Journal of biological chemistry. 256(15):7925-31 [PMID] 6790529.
1981
Altered states of cardiac beta-adrenoreceptors.
Biochemical pharmacology. 30(24):3361-4 [PMID] 6275859.
1981
Effect of thyroid status on beta-adrenoreceptors and muscarinic receptors in the rat lung.
Journal of autonomic pharmacology. 1(4):269-77 [PMID] 6279669.
1980
Biochemical studies of cardiac beta-adrenoceptors, and their clinical significance.
Circulation research. 46(6 Pt 2):I38-42 [PMID] 6247092.
1980
Cardiac beta-adrenoceptors during normal growth of male and female rats.
British journal of pharmacology. 68(1):65-70 [PMID] 6244033.
1980
Distribution and function of beta-adrenoceptors in different chambers of the canine heart.
British journal of pharmacology. 68(1):57-63 [PMID] 6244032.
1980
Effect of propranolol on beta-adrenoceptors in rat hearts.
British journal of pharmacology. 68(1):8-10 [PMID] 6244034.
1980
Purification and partial characterization of cardiac plasma membranes rich in beta-adrenoreceptors.
Membrane biochemistry. 3(3):185-205 [PMID] 6247606.
1978
beta-adrenergic receptor and adenylate cyclase in transverse tubules of skeletal muscle.
The Journal of biological chemistry. 253(9):3049-54 [PMID] 205539.
1975
Proceedings: Some studies on the purification of monoamine oxidase by affinity chromatography.
British journal of pharmacology. 54(2):274P-275P [PMID] 1170915.
1957
Heparin-activated clearing factor; standardized test, agewise application, and clinical observations.
Circulation. 15(6):889-96 [PMID] 13437414.
1954
Anuria produced by alpha-naphthyl thiourea.
The American journal of physiology. 179(3):457-61 [PMID] 13228608.

Contact Details

Phones:
Business:
(352) 294-5358
Emails:
Business:
spbaker@ufl.edu
Addresses:
Business Mailing:
PO Box 100267
GAINESVILLE FL 32610
Business Street:
1200 NEWELL DRIVE ARB R5-234
GAINESVILLE FL 32610